Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags Read more →

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare Read more →

Enveda reaps $311M series E to feed ambition to become a ‘household name’ Read more →